LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
$1,260.66
+4.30% today · +7.79% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Moving with its weight-loss drugs peers
- LLY +4.30% on the last session vs SPY −0.29%: +4.6 pts of stock-specific move.
- Weight-loss drugs basket +4.5% (+4.8 pts vs SPY; VKTX +5.5%, NVO +3.5%): the stock moved with its peers.
- Aftermath, big gain (+4.3% today so far, past its big-gain line of +2.7%): After its 67 big gains in the past 5 years, LLY was higher a week later 40 times out of 67; half the outcomes fell between -2.4% and +3.6%. History, not a forecast.
- 2 analyst actions in the past 10 days (2 positive, 0 negative); latest: Cantor Fitzgerald maintained Overweight, raised target $1,410 → $1,440.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
- Activity: volume on pace for 2.6× its 20-day average.
Assembled from Wallsti's own signals.
Insiders · 1 month
none
no open-market trades
Insiders · 3 months
$0
unplanned net · 0 buys · 3 sells · 3 insiders
sales: 0 unplanned, 3 under a 10b5-1 plan (0% unplanned)
Congress · 3 months
none
no reported trades
Congress · 1 year
≈+$67.5K
10 buys · 13 sells · 12 members
Fund moves · 3 months
≈+$34.3M
2 buys · 0 sells · 2 investors
Held by funds · now
≈$260.8M
4 investors · largest: ARK Invest
Insiders
| Trade date | Insider | Role | Side | Type | Shares | Avg price | Value | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Patrik Jonsson | President | Sell | 10b5-1 plan | 6,500 | $1,175.10 | $7.6M | Aug 18 |
| Aug 10, 2026 | Donald A Zakrowski | SVP | Sell | 10b5-1 plan | 2,000 | $1,185.01 | $2.4M | Aug 11 |
| Aug 7, 2026 | Anat Hakim | EVP | Sell | 10b5-1 plan | 5,000 | $1,190.00 | $6M | Aug 10 |
| Aug 1, 2026 | Melissa Seymour | EVP | Tax | tax withholding | 438.707 | $1,148.84 | $504K | Aug 3 |
| Jun 10, 2026 | Ilya Yuffa | EVP | Sell | 10b5-1 plan | 2,500 | $1,150.77 | $2.9M | Jun 11 |
| May 6, 2026 | Lilly Endowment Inc | Insider | Sell | unplanned | 15,828 | $995.36 | $15.8M | May 7 |
| Feb 16, 2026 | Adrienne S Brown | President | Tax | tax withholding | 169.966 | $1,040.00 | $176.8K | Feb 18 |
| Feb 16, 2026 | Kenneth L. Custer | President | Tax | tax withholding | 91.311 | $1,040.00 | $95K | Feb 18 |
| Feb 16, 2026 | Lucas Montarce | CFO | Tax | tax withholding | 159.733 | $1,040.00 | $166.1K | Feb 18 |
| Feb 16, 2026 | Donald A Zakrowski | SVP | Tax | tax withholding | 81.553 | $1,040.00 | $84.8K | Feb 18 |
| Feb 1, 2026 | Eric Dozier | EVP | Tax | tax withholding | 1,272.992 | $1,037.15 | $1.3M | Feb 3 |
| Feb 1, 2026 | Anat Hakim | EVP | Tax | tax withholding | 2,953.395 | $1,037.15 | $3.1M | Feb 3 |
| Feb 1, 2026 | Edgardo Hernandez | EVP | Tax | tax withholding | 1,591.452 | $1,037.15 | $1.7M | Feb 3 |
| Feb 1, 2026 | Patrik Jonsson | President | Tax | tax withholding | 1,752.071 | $1,037.15 | $1.8M | Feb 3 |
| Feb 1, 2026 | Diogo Rau | EVP | Tax | tax withholding | 1,673.538 | $1,037.15 | $1.7M | Feb 3 |
| Feb 1, 2026 | David A Ricks | CEO | Tax | tax withholding | 14,296.654 | $1,037.15 | $14.8M | Feb 3 |
| Feb 1, 2026 | Naarden Jacob Van | EVP | Tax | tax withholding | 1,909.375 | $1,037.15 | $2M | Feb 3 |
| Feb 1, 2026 | Daniel Skovronsky | EVP | Tax | tax withholding | 5,641.249 | $1,037.15 | $5.9M | Feb 3 |
| Feb 1, 2026 | Ilya Yuffa | EVP | Tax | tax withholding | 1,512.364 | $1,037.15 | $1.6M | Feb 3 |
| Jan 7, 2026 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 292,148 | $1,103.48 | $322.4M | Jan 8 |
| Jan 5, 2026 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 1,390 | $1,085.01 | $1.5M | Jan 6 |
| Dec 29, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 3,593 | $1,085.04 | $3.9M | Dec 30 |
| Dec 24, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 2,629 | $1,085.17 | $2.9M | Dec 29 |
| Dec 23, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 240 | $1,085.04 | $260.4K | Dec 29 |
| Nov 25, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 147,061 | $1,095.35 | $161.1M | Nov 26 |
| Nov 25, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 15,632 | $1,109.30 | $17.3M | Nov 26 |
| Nov 24, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 142,307 | $1,068.52 | $152.1M | Nov 25 |
| Nov 21, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 105,326 | $1,058.66 | $111.5M | Nov 24 |
| Nov 20, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 37,148 | $1,051.66 | $39.1M | Nov 21 |
| Nov 19, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 167,526 | $1,051.17 | $176.1M | Nov 20 |
| Nov 18, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 60,213 | $1,034.78 | $62.3M | Nov 19 |
| Nov 17, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 9,886 | $1,030.68 | $10.2M | Nov 18 |
| Nov 14, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 178,295 | $425,738.48 | $75.9B | Nov 17 |
| Nov 13, 2025 | Donald A Zakrowski | SVP | Sell | 10b5-1 plan | 1,000 | $1,010.50 | $1M | Nov 13 |
| Nov 13, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 46,606 | $1,030.26 | $48M | Nov 14 |
| Nov 12, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 305,000 | $1,011.18 | $308.4M | Nov 13 |
| Nov 11, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 283,131 | $986.64 | $279.3M | Nov 12 |
| Nov 10, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 16,869 | $972.52 | $16.4M | Nov 12 |
| Nov 5, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 179,042 | $933.26 | $167.1M | Nov 6 |
| Nov 5, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 40,432 | $951.56 | $38.5M | Nov 6 |
| Nov 4, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 526 | $910.72 | $479K | Nov 5 |
| Nov 3, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 300,000 | $888.83 | $266.6M | Nov 4 |
| Oct 31, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 301,342 | $863.35 | $260.2M | Nov 3 |
| Oct 10, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 3,658 | $863.24 | $3.2M | Oct 14 |
| Oct 9, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 10,602 | $852.49 | $9M | Oct 10 |
| Oct 8, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 101,420 | $850.27 | $86.2M | Oct 9 |
| Oct 7, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 26,795 | $848.01 | $22.7M | Oct 8 |
| Oct 6, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 161,183 | $850.22 | $137M | Oct 7 |
| Oct 3, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 192,404 | $837.93 | $161.2M | Oct 6 |
| Oct 2, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 112,596 | $821.55 | $92.5M | Oct 3 |
| Oct 1, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 135,193 | $794.15 | $107.4M | Oct 2 |
| Oct 1, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 215,822 | $821.47 | $177.3M | Oct 2 |
| Sep 30, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 113,694 | $763.39 | $86.8M | Oct 1 |
| Sep 19, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 23,665 | $763.10 | $18.1M | Sep 22 |
| Sep 18, 2025 | Lilly Endowment Inc | 10% owner | Sell | unplanned | 106,626 | $764.65 | $81.5M | Sep 19 |
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
| Trade date | Member | Chamber | Side | Amount | Disclosed |
|---|---|---|---|---|---|
| Jul 10, 2026 | Dan Newhouse | House | Sell | $1K–$15K | Jul 17 |
| Jul 1, 2026 | Michael Rulli | House | Sell | $1K–$15K | Aug 7 |
| Jun 10, 2026 | Gilbert Cisneros | House | Buy | $50K–$100K | Jul 2 |
| Apr 14, 2026 | Gilbert Cisneros | House | Buy | $1K–$15K | May 8 |
| Apr 8, 2026 | Elizabeth Fletcher | House | Sell | $1K–$15K | May 1 |
| Apr 2, 2026 | Byron Donalds | House | Buy | $1K–$15K | May 13 |
| Apr 2, 2026 | Byron Donalds | House | Buy | $1K–$15K | May 13 |
| Mar 27, 2026 | Alan Armstrong | Senate | Sell | $1K–$15K | Jul 21 |
| Feb 26, 2026 | David J. Taylor | House | Buy | $1K–$15K | Mar 6 |
| Feb 13, 2026 | Angus S King, Jr. | Senate | Sell | $1K–$15K | Mar 24 |
| Feb 9, 2026 | David J. Taylor | House | Sell | $1K–$15K | Feb 20 |
| Jan 16, 2026 | David J. Taylor | House | Sell | $1K–$15K | Feb 2 |
| Jan 2, 2026 | Michael Rulli | House | Buy | $1K–$15K | Aug 7 |
| Dec 29, 2025 | Markwayne Mullin | Senate | Buy | $15K–$50K | Jan 16 |
| Dec 29, 2025 | Angus S King, Jr. | Senate | Buy | $1K–$15K | Jan 26 |
| Dec 18, 2025 | Julie Johnson | House | Sell | $1K–$15K | Jan 15 |
| Dec 10, 2025 | David J. Taylor | House | Sell | $1K–$15K | Dec 19 |
| Dec 2, 2025 | Michael Rulli | House | Sell | $1K–$15K | Aug 7 |
| Nov 21, 2025 | John Boozman | Senate | Sell | $1K–$15K | Dec 8 |
| Nov 21, 2025 | John Boozman | Senate | Sell | $1K–$15K | Aug 24 |
| Nov 18, 2025 | Gilbert Cisneros | House | Buy | $1K–$15K | Dec 15 |
| Nov 13, 2025 | Julie Johnson | House | Sell | $1K–$15K | Dec 11 |
| Oct 24, 2025 | Shelley M Capito | Senate | Buy | $1K–$15K | Nov 4 |
| Sep 23, 2025 | Valerie Hoyle | House | Sell | $1K–$15K | Oct 10 |
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily.
Funds
Who holds it
| Investor | Shares | Value | Of its portfolio | Vs quarter before | As of |
|---|---|---|---|---|---|
| ARK Invest (Cathie Wood) | 95,086 | $114.9M | ARKG 4.0% · ARKK 0.5% | — | Oct 15 |
| Bridgewater (Ray Dalio's firm) | 87,023 | $104.4M | 0.43% | +23% | Q2 2026 |
| Soros Fund Management (George Soros) | 22,199 | $26.6M | 0.44% | — | Q2 2026 |
| Duquesne Family Office (Stanley Druckenmiller) | 12,380 | $14.8M | 0.34% | new | Q2 2026 |
Their moves
| Date | Investor | Move | Source | Shares | ≈ Value | Now held | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Bridgewater (Ray Dalio's firm) | Added | 13F, Q2 2026 | 16,211 | $19.4M | 0.4% | Aug 14 |
| Aug 14, 2026 | Duquesne Family Office (Stanley Druckenmiller) | New stake | 13F, Q2 2026 | 12,380 | $14.8M | 0.3% | Aug 14 |
| Feb 13, 2026 | Soros Fund Management (George Soros) | New stake | 13F, Q4 2025 | 22,334 | $24M | 0.4% | Feb 13 |
| Feb 13, 2026 | Bridgewater (Ray Dalio's firm) | Added | 13F, Q4 2025 | 62,851 | $67.5M | 0.3% | Feb 13 |
| Nov 14, 2025 | Viking Global (Andreas Halvorsen) | Sold out | 13F, Q3 2025 | 416,918 | $325M | Nov 14 | |
| Nov 14, 2025 | Coatue (Philippe Laffont) | Sold out | 13F, Q3 2025 | 117,415 | $91.5M | Nov 14 | |
| Nov 14, 2025 | Tiger Global (Chase Coleman) | Sold out | 13F, Q3 2025 | 1,511,160 | $1.2B | Nov 14 | |
| Nov 14, 2025 | Duquesne Family Office (Stanley Druckenmiller) | Sold out | 13F, Q3 2025 | 100,675 | $78.5M | Nov 14 |
Well-known investors we follow (Buffett, Ackman, Icahn, Druckenmiller, Tepper, Soros and others). 13F: managers report their US stock holdings up to 45 days after each quarter; the change from the quarter before is dated by the filing, the trades happened some time in the quarter, and the value is at the quarter-end price (≈). New and closed positions, and adds or cuts of 20% or more, of positions at least 0.2% of the portfolio. ARK: Cathie Wood's ETFs publish their holdings every morning; the change beyond the fund's own inflows and outflows, dated by the session it traded. 5%+ stake: Schedule 13D (with intent to influence) or 13G (passive), filed within days. Source: SEC EDGAR, ark-funds.com, refreshed daily. Who holds it: each investor's latest 13F portfolio (positions at the quarter's end; one sold since would not show until the next filing), and ARK's ETFs as of their latest daily file. The funds we follow and their portfolios · All recent insider, congressional and fund moves